This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $14,995.64 contract is for the delivery of Betaseron 0.3 mg kits, a specialized medication.
The contract is not associated with a set-aside designation, allowing DMS Pharmaceutical Group to leverage its woman-owned small business status to secure this direct federal award. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. This contract award is part of that broader IDC vehicle, positioning DMS Pharmaceutical Group as a crucial supplier in the federal pharmaceutical supply chain.
Generated 2/21/25, 10:00 AM